No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr11:113240200-113258400 |
Weak transcription |
Spleen |
Spleen
|
2 |
chr11:113249200-113258200 |
Weak transcription |
ES-WA7 Cell Line |
embryonic stem cell
|
3 |
chr11:113255400-113258200 |
Enhancers |
HMEC |
breast
|
4 |
chr11:113255400-113258400 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
5 |
chr11:113255600-113258200 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
6 |
chr11:113255800-113258200 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
7 |
chr11:113256000-113258200 |
Weak transcription |
Placenta Amnion |
Placenta Amnion
|
8 |
chr11:113257000-113260200 |
Weak transcription |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
9 |
chr11:113257400-113258200 |
Enhancers |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
10 |
chr11:113257400-113258200 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
11 |
chr11:113257400-113258400 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
12 |
chr11:113257400-113258400 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
13 |
chr11:113257600-113258200 |
Bivalent Enhancer |
H1 Cell Line |
embryonic stem cell
|
14 |
chr11:113257600-113258200 |
Bivalent Enhancer |
HUES64 Cell Line |
embryonic stem cell
|
15 |
chr11:113257600-113258200 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
16 |
chr11:113257600-113258400 |
Weak transcription |
Lung |
lung
|
17 |
chr11:113257600-113259200 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
18 |
chr11:113257800-113258200 |
Enhancers |
H9 Cell Line |
embryonic stem cell
|
19 |
chr11:113257800-113258200 |
Bivalent Enhancer |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
20 |
chr11:113257800-113258200 |
Bivalent Enhancer |
iPS-15b Cell Line |
embryonic stem cell
|
21 |
chr11:113257800-113258400 |
Flanking Active TSS |
Breast Myoepithelial Primary Cells |
Breast
|
22 |
chr11:113257800-113258800 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
23 |
chr11:113258000-113258400 |
Flanking Bivalent TSS/Enh |
ES-I3 Cell Line |
embryonic stem cell
|
24 |
chr11:113258000-113258400 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
25 |
chr11:113258000-113258400 |
Flanking Bivalent TSS/Enh |
iPS-18 Cell Line |
embryonic stem cell
|
26 |
chr11:113258000-113258400 |
Flanking Bivalent TSS/Enh |
iPS-20b Cell Line |
embryonic stem cell
|
27 |
chr11:113258000-113258600 |
Flanking Bivalent TSS/Enh |
HUES6 Cell Line |
embryonic stem cell
|
28 |
chr11:113258000-113258600 |
Enhancers |
HUVEC |
blood vessel
|
29 |
chr11:113258000-113258800 |
Active TSS |
HUES48 Cell Line |
embryonic stem cell
|
30 |
chr11:113258000-113259200 |
Flanking Active TSS |
NHEK |
skin
|
31 |
chr11:113258000-113272200 |
Weak transcription |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|